New vaccines will act on the principle of the oldThe American biotechnology company Moderna has begun developing three new vaccines – against herpes simplex virus type 2, cancer and chickenpox.Discuss
It is noted that the drugs are based on the same technology used in the COVID-19 vaccine. This is messenger RNA (mRNA) technology.
The first vaccine against herpes, according to Moderna, will allow 5% -13% of the world's population aged 18-49 to get rid of a chronic infection in their body. The second vaccine will work against the varicella-zoster virus. Because of it, herpes zoster may subsequently appear, and sometimes even a number of complications, up to nerve damage and paralysis.
The third vaccine will protect “immunological checkpoints” from exposure to certain types of cancer.”
Source: TJ